1.47 USD
+0.05 (+3.52%)
1.4203 USD
-0.05 (-3.38%)
ChartMill assigns a Buy % Consensus number of 84% to MRKR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.33. This target is 466.67% above the current price.
MRKR was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MRKR.
In the previous month the buy percentage consensus was at a similar level.
MRKR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2025-04-01 | WBB Securities | Reiterate | Strong Buy -> Strong Buy |
| 2025-03-05 | Canaccord Genuity | Initiate | Buy |
| 2024-10-21 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2024-04-30 | Ladenburg Thalmann | Initiate | Buy |
| 2022-02-17 | Roth Capital | Downgrade | Buy -> Neutral |
| 2021-03-25 | Piper Sandler | Initiate | Overweight |
| 2021-03-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-18 | Cantor Fitzgerald | Initiate | Overweight |
MARKER THERAPEUTICS INC / MRKR FAQ
What is the price target for MRKR stock?
9 analysts have analysed MRKR and the average price target is 8.33 USD. This implies a price increase of 466.67% is expected in the next year compared to the current price of 1.47.
Can you provide the consensus rating for MARKER THERAPEUTICS INC stock?
The consensus rating for MARKER THERAPEUTICS INC (MRKR) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for MRKR stock?
The number of analysts covering MARKER THERAPEUTICS INC (MRKR) is 9.